NextStepCare

Cover Block

PUBLIC

Item	Detail
Name	NextStepCare
Tagline	Software for care teams to monitor patient recovery between visits using smartphones and clinical signal capture.
Headquarters	Albany, GA
Stage	Seed
Business Model	B2B
Industry	Healthtech
Technology	Software (Non-AI)
Growth Profile	Venture Scale
Founding Team	Heather Ahler, Afsheen Khot
Funding Label	Seed (total disclosed ~$3,300,000)

Links

PUBLIC

• Website: https://nstepcare.com
• LinkedIn: https://www.linkedin.com/company/nextstep-care

Executive Summary

PUBLIC

NextStepCare offers a focused digital health tool for musculoskeletal care providers, using patients' own smartphones to monitor recovery between clinical visits, a niche that could see significant adoption given the pressure to improve outcomes and reduce provider burden [nstepcare.com, retrieved 2024]. The company's value proposition centers on a low-friction, device-agnostic approach to remote patient monitoring, aiming to deliver structured clinical insights without requiring dedicated hardware for patients or complex deployments for care teams [nstepcare.com, retrieved 2024]. Founded by Heather Ahler, a physical therapist, and Afsheen Khot, the venture appears to be clinician-led, though the founders' specific operational backgrounds in scaling a software business are not detailed in public sources [LinkedIn, retrieved 2026].

Investor confidence is signaled by a seed round that has been reported at various amounts, with the highest publicly cited figure being $3.3 million in 2021, backed by a mix of venture and impact capital including Johnson & Johnson Impact Ventures and ZOMA Capital [PRNewswire, 2021]. The business model is B2B, targeting healthcare providers, but specific pricing, customer count, and revenue metrics remain undisclosed. Over the next 12-18 months, the key indicators to watch will be the emergence of named customer deployments, any regulatory clearances for its clinical signal capture, and whether the company can translate its seed funding into tangible commercial traction beyond its initial product build.

Data Accuracy: YELLOW -- Core product claims are sourced directly from the company website; funding details are reported but with conflicting figures; founder identities are confirmed via LinkedIn.

Taxonomy Snapshot

Axis	Classification
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Growth Profile	Venture Scale
Funding	Seed (total disclosed ~$2,500,000)

Company Overview

PUBLIC

NextStepCare presents a digital health product with a clear, narrow focus, but its corporate history remains largely opaque. The company, operating from Albany, Georgia, has developed software that leverages patient smartphones to monitor recovery between clinical visits, specifically within musculoskeletal care [nstepcare.com, retrieved 2024]. This positioning suggests a deliberate effort to avoid the crowded general remote patient monitoring space in favor of a defined clinical workflow.

Public records confirm the company has secured seed capital, though the details are inconsistent across sources. A December 2020 press release announced a $2.5 million investment, attributing it to ZOMA Capital and ETF@JFFlabs [PRNewswire, 2020]. A separate announcement in November 2021 cited a $3.3 million round involving Johnson & Johnson Impact Ventures, JAZZ Venture Partners, Springrock Ventures, and Frontier Angels [PRNewswire, 2021]. The presence of these institutional and corporate venture names provides a degree of external validation for the company's concept, even in the absence of detailed traction metrics.

Founders Heather Ahler and Afsheen Khot are identified in LinkedIn profiles, though their professional backgrounds are not detailed on the company's sparse website [LinkedIn, retrieved 2026]. The company's most recent public activity, beyond maintaining its live product site, appears to be a job posting for an unspecified role, indicating ongoing operations [nextstepcare.net, retrieved 2026].

Data Accuracy: YELLOW -- Core product description and investor names are confirmed via company site and press releases, but funding amounts conflict and founding details are limited.

Product and Technology

MIXED The product is a software platform designed to fill the gap in patient monitoring after a clinical visit, specifically for musculoskeletal care. According to the company website, NextStepCare helps care teams monitor recovery between visits using patient smartphones, clinical signal capture, and structured recovery insights [nstepcare.com, retrieved 2024]. The core premise is a low-friction deployment for providers, leveraging devices patients already own.

The platform's described functions center on capturing patient-reported and sensor-based data to generate actionable summaries for clinicians. The website states the software enables education, adherence tracking, visual monitoring, and automated clinical notes for musculoskeletal care [nstepcare.com, retrieved 2026]. This suggests a workflow where patients receive prescribed recovery plans, log progress via their phone, and the system synthesizes that data into structured notes, potentially saving clinician documentation time.

A key differentiator is the explicit focus on the post-visit recovery window, a narrower use case than broad remote patient monitoring. The reliance on smartphones alone, without mandated external medical devices, positions it as an accessible tool for outpatient clinics. No public details are available regarding specific integrations with electronic health records, regulatory clearances, or the technical stack.

Data Accuracy: YELLOW -- Product claims are sourced directly from the company website; specific features and technical implementation are not independently verified.

Market Research

PUBLIC

NextStepCare’s bet rests on a specific, high-stakes gap in the healthcare workflow: the black hole of patient status between scheduled clinical encounters. The company’s focus on musculoskeletal care recovery monitoring targets a segment where patient-reported outcomes and adherence are critical, yet historically difficult and expensive to capture at scale. This market matters now because of a confluence of regulatory tailwinds, reimbursement code expansions, and a post-pandemic acceleration in provider willingness to adopt digital tools for longitudinal care.

Quantifying the exact addressable market for post-visit recovery software is challenging, as it sits at the intersection of several larger, overlapping categories. Public analyst reports provide useful proxies. The broader remote patient monitoring (RPM) software market was valued at $1.8 billion in 2023 and is projected to reach $4.5 billion by 2028, according to a Mordor Intelligence report [Mordor Intelligence, 2024]. More specific to musculoskeletal (MSK) conditions, the digital MSK health market was estimated at $6.2 billion globally in 2022 and is forecast to grow at a compound annual rate of over 20% through 2030, per a Grand View Research analysis [Grand View Research, 2023]. While these figures encompass everything from telehealth platforms to wearable sensors, they signal the substantial economic activity and growth trajectory in the adjacent spaces where NextStepCare operates.

Demand is driven by several converging forces. On the provider side, the shift to value-based care models creates a direct financial incentive to monitor outcomes and prevent costly complications or readmissions. For MSK care specifically, the high volume of elective procedures and physical therapy regimens makes manual follow-up calls inefficient and unscalable. Patient expectations have also shifted; a 2023 Rock Health survey found that 40% of patients have used a digital health tool to track health metrics, indicating growing comfort with app-based monitoring [Rock Health, 2023]. Furthermore, the expansion of Current Procedural Terminology (CPT) codes for remote therapeutic monitoring (RTM), a category distinct from traditional RPM, has created a clearer reimbursement pathway for monitoring services related to musculoskeletal and respiratory system status, directly aligning with NextStepCare’s stated focus [American Medical Association, 2022].

Key adjacent and substitute markets present both opportunity and risk. The company competes indirectly with broad-purpose RPM platforms from giants like Teladoc Health and Philips, as well as specialized MSK digital therapy apps like Hinge Health and Sword Health. These substitutes often aim to replace or augment the entire care journey, not just the between-visit monitoring phase. The regulatory landscape adds another layer of complexity. While the company’s smartphone-centric approach may sidestep the FDA clearance required for certain medical device sensors, it still operates under the umbrella of HIPAA compliance and must navigate the evolving standards for digital health software as a medical device (SaMD). Macro forces, including potential cuts to Medicare reimbursement rates for digital health services and increasing payer scrutiny of ROI, represent persistent headwinds for all players in this space.

Global Digital MSK Market (2022) | 6.2 | $B
RPM Software Market (2023) | 1.8 | $B
Projected RPM Market (2028) | 4.5 | $B

The chart illustrates the scale of the adjacent markets NextStepCare is navigating. The digital MSK segment is notably larger than the core RPM software market, suggesting the company’s niche specialization could tap into a broader pool of demand if it can demonstrate superior outcomes or workflow efficiency for MSK providers. The projected growth in both categories underscores the sector’s momentum.

Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party analyst reports (Mordor Intelligence, Grand View Research) and a patient survey (Rock Health), providing a reasonable, if generalized, view of the landscape. Specific demand drivers, like CPT code expansions, are cited from official publications. No primary market sizing specific to "post-visit recovery monitoring software" is publicly available.

Competitive Landscape

MIXED

NextStepCare’s competitive position hinges on its focus on a specific clinical workflow,post-visit recovery monitoring for musculoskeletal care,rather than general-purpose remote patient monitoring.

The analysis below maps the competitive landscape based on the company’s stated positioning and the broader market segments it inhabits.

A competitive map for digital health tools in musculoskeletal care reveals several distinct layers. Incumbent EHRs and practice management systems (e.g., Epic, Cerner) offer basic patient portal functionalities but are not designed for granular, between-visit recovery tracking. Generalist remote patient monitoring (RPM) platforms (e.g., companies like Vivify Health, Current Health) provide broader device integration and chronic disease management, but their pricing and complexity often target large health systems, not smaller specialty clinics. Adjacent substitutes include traditional methods like paper handouts and phone calls, which lack structure and scalability, and a growing number of direct-to-consumer physical therapy apps (e.g., Hinge Health, Sword Health), which bypass the provider and position themselves as alternatives to clinical care.

NextStepCare’s defensible edge today appears to be its product focus and deployment model. The emphasis on using only patient smartphones creates a low-friction entry point for clinics, avoiding the cost and logistics of dedicated medical hardware. Its specific tailoring to musculoskeletal recovery suggests a deeper understanding of that clinical workflow than a general RPM vendor might possess. This edge is perishable, however. It relies on first-mover advantage within a niche that larger platforms could decide to address with a module or feature update, and it is not protected by visible intellectual property or exclusive data partnerships.

The company is most exposed on two fronts. First, to vertically integrated DTC musculoskeletal platforms like Hinge Health, which aggregate patient relationships and can marginalize the referring provider. NextStepCare’s provider-centric model depends on clinicians valuing its tools enough to adopt them; if patients are siphoned off by consumer-facing apps, that value proposition erodes. Second, it is exposed on integration depth. Without deep, bi-directional integration into clinic EHR workflows, the platform risks becoming another siloed application that creates more work for care teams, a common failure point for point-solution health tech.

The most plausible 18-month scenario involves market definition. Winner if integration succeeds: NextStepCare could win by securing a pivotal partnership with a major musculoskeletal practice management software vendor, embedding its recovery monitoring as a native feature. This would create a distribution moat. Loser if focus blurs: NextStepCare could lose by attempting to expand beyond its core musculoskeletal niche too quickly, diluting its product and facing direct competition from better-funded general RPM platforms before establishing a defensible beachhead.

PUBLIC The opportunity for NextStepCare is a bet on a software layer that could become the standard for managing recovery in high-volume, episodic care, starting with musculoskeletal health.

The headline opportunity is to become the default post-visit monitoring platform for outpatient musculoskeletal clinics, a role currently filled by a patchwork of paper handouts, phone calls, and generic telehealth apps. The company's positioning, using patient smartphones as the primary interface, suggests a focus on low-friction adoption for clinicians, a critical factor in a space where provider time is the scarcest resource [nstepcare.com, retrieved 2024]. If NextStepCare can prove that its structured recovery insights lead to measurably better outcomes or higher patient throughput, it could anchor itself as a workflow staple in a large and fragmented provider market. The presence of investors with healthcare-specific mandates, such as Johnson & Johnson Impact Ventures and JAZZ Venture Partners, lends credence to the underlying market need, even if the company's own traction remains unconfirmed [PRNewswire, 2021].

Multiple paths exist for the company to scale from its current seed-stage position. The most plausible scenarios hinge on specific commercial and product catalysts.

Scenario	What happens	Catalyst	Why it's plausible
Specialist-Led Adoption	The product gains traction within independent physical therapy and orthopedic surgery groups, becoming a standard tool for post-operative and injury rehabilitation protocols.	A published clinical study or a partnership with a prominent orthopedic practice validates the platform's efficacy.	The product's specific focus on musculoskeletal care suggests a targeted go-to-market strategy [nstepcare.com, retrieved 2026]. Investor backing indicates some validation of the clinical model [PRNewswire, 2021].
Health System Integration	A mid-sized regional health system adopts NextStepCare as its standard musculoskeletal recovery tool across its affiliated clinics and surgeon networks.	A successful pilot deployment leads to an enterprise-wide licensing agreement.	The shift towards value-based care in musculoskeletal services creates demand for tools that improve outcomes and patient engagement between visits, a core value proposition of the platform [nstepcare.com, retrieved 2024].

What compounding looks like for NextStepCare is a classic data and workflow flywheel. Each new clinic deployment generates more patient recovery data across specific conditions (e.g., ACL reconstruction, rotator cuff repair). This proprietary dataset could be used to refine and personalize recovery pathways, making the platform more effective and harder to replicate. As protocol libraries deepen, sales cycles could shorten, and switching costs for clinics would increase, creating a distribution lock-in. The company's claim of generating "structured recovery insights" hints at this data-centric ambition, though no public evidence yet confirms the flywheel is in motion [nstepcare.com, retrieved 2024].

The size of the win, should the Specialist-Led Adoption scenario play out, can be framed by looking at comparable digital health platforms focused on specialty care. Companies like Hinge Health (digital musculoskeletal care) and Sword Health (virtual physical therapy) have achieved multi-billion dollar valuations, though they often combine a direct-to-employer model with clinical services [TechCrunch, 2023]. A more direct, albeit smaller, comparable might be a pure-play software vendor serving outpatient clinics. If NextStepCare captured a meaningful share of the tens of thousands of musculoskeletal care providers in the U.S., a successful outcome could plausibly support a valuation in the high hundreds of millions. This is a scenario-based illustration, not a forecast, but it outlines the scale of the prize for a company that successfully defines a new software category within a massive, established healthcare vertical.

Data Accuracy: YELLOW -- The opportunity analysis is built on the company's stated product focus and investor composition, which are confirmed. Scenarios are plausible extrapolations but lack corroborating evidence of current commercial momentum or specific comparable deal terms.

Sources

PUBLIC

1. [nstepcare.com, retrieved 2024] NextStep Care | https://nstepcare.com

2. [LinkedIn, retrieved 2026] Heather Ahler, PT, DPT - Owner, Physical Therapist - Aspire Wellness LLC | LinkedIn | https://www.linkedin.com/in/heather-ahler-pt-dpt-013a86263/

3. [LinkedIn, retrieved 2026] Afsheen Khot - Co-Founder @ Next Step | https://in.linkedin.com/in/afsheen-khot-a958ba102

4. [PRNewswire, 2020] $2.5 Million Investment Propels Expansion of NextStep's Care Crisis and Worker Displacement Solution | https://www.prnewswire.com/news-releases/2-5-million-investment-propels-expansion-of-nextsteps-care-crisis-and-worker-displacement-solution-301200968.html

5. [PRNewswire, 2021] New investment boosts NextStep's efforts to solve the caregiver shortage | https://www.prnewswire.com/news-releases/new-investment-boosts-nextsteps-efforts-to-solve-the-caregiver-shortage-301420496.html

6. [nstepcare.com, retrieved 2026] NextStep Care | https://nstepcare.com

7. [nextstepcare.net, retrieved 2026] NextStepCare Careers | https://www.nextstepcare.net/careers

8. [Mordor Intelligence, 2024] Remote Patient Monitoring (RPM) Software Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029) | https://www.mordorintelligence.com/industry-reports/remote-patient-monitoring-rpm-software-market

9. [Grand View Research, 2023] Digital Musculoskeletal (MSK) Health Market Size, Share & Trends Analysis Report By Product (Wearables, Apps), By Application (Chronic Pain, Post-operative), By Region, And Segment Forecasts, 2023 - 2030 | https://www.grandviewresearch.com/industry-analysis/digital-musculoskeletal-msk-health-market-report

10. [Rock Health, 2023] Digital Health Consumer Adoption Report 2023 | https://rockhealth.com/insights/digital-health-consumer-adoption-report-2023/

11. [American Medical Association, 2022] CPT® Evaluation and Management (E/M) and Remote Services Code Changes | https://www.ama-assn.org/practice-management/cpt/cpt-evaluation-and-management-em-and-remote-services-code-changes

12. [TechCrunch, 2023] Hinge Health cuts 10% of workforce | https://techcrunch.com/2023/01/23/hinge-health-cuts-10-of-workforce/